serw-MX  [xml]  
 


    
 DeCS Categories

A12 Fluids and Secretions .
A12.207 Body Fluids .
A12.207.152 Blood .
A12.207.152.846 Serum .
A15 Hemic and Immune Systems .
A15.145 Blood .
A15.145.846 Serum .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.470 Inflammation .
C23.550.470.640 Seroma .
D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.100 Amino Alcohols .
D02.033.100.291 Ethanolamines .
D02.033.100.291.057 Albuterol .
D02.033.100.291.057.750 Salmeterol Xinafoate .
D02.033.100.291.057.750.500 Fluticasone-Salmeterol Drug Combination .
D02.092 Amines .
D02.092.063 Amino Alcohols .
D02.092.063.291 Ethanolamines .
D02.092.063.291.057 Albuterol .
D02.092.063.291.057.750 Salmeterol Xinafoate .
D02.092.063.291.057.750.500 Fluticasone-Salmeterol Drug Combination .
D02.092.471 Ethylamines .
D02.092.471.683 Phenethylamines .
D02.092.471.683.061 Albuterol .
D02.092.471.683.061.750 Salmeterol Xinafoate .
D02.092.471.683.061.750.500 Fluticasone-Salmeterol Drug Combination .
D02.442 Hydrazines .
D02.442.175 Benserazide .
D02.886 Sulfur Compounds .
D02.886.590 Sulfones .
D02.886.590.700 Sulfonamides .
D02.886.590.700.135 Benzothiadiazines .
D02.886.590.700.135.261 Chlorothiazide .
D02.886.590.700.135.261.476 Hydrochlorothiazide .
D02.886.655 Thiazides .
D02.886.655.500 Benzothiadiazines .
D02.886.655.500.261 Chlorothiazide .
D02.886.655.500.261.476 Hydrochlorothiazide .
D03 Heterocyclic Compounds .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.079 Benzazepines .
D03.633.100.079.080 Benzodiazepines .
D03.633.100.079.080.070 Benzodiazepinones .
D03.633.100.079.080.070.663 Oxazepam .
D03.633.100.174 Benzothiadiazines .
D03.633.100.174.261 Chlorothiazide .
D03.633.100.174.261.476 Hydrochlorothiazide .
D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.054 Androstanes .
D04.210.500.054.079 Androstenes .
D04.210.500.054.079.129 Androstadienes .
D04.210.500.054.079.129.114 Fluticasone .
D04.210.500.054.079.129.114.500 Fluticasone-Salmeterol Drug Combination .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.347.360 Estrogen Receptor Modulators .
D06.347.360.827 Selective Estrogen Receptor Modulators .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.154 Amino Acids, Neutral .
D12.125.154.800 Serine .
D13 Nucleic Acids, Nucleotides, and Nucleosides .
D13.570 Nucleosides .
D13.570.800 Ribonucleosides .
D13.570.800.790 Ribavirin .
D26 Pharmaceutical Preparations .
D26.310 Drug Combinations .
D26.310.438 Fluticasone-Salmeterol Drug Combination .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.450.360 Estrogen Receptor Modulators .
D27.505.696.399.450.360.827 Selective Estrogen Receptor Modulators .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Benserazide .
DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide .
Ro 4-4602 .
Seryltrihydroxy Benzylhydrazine .
Benzylhydrazine, Seryltrihydroxy .
Ro 4 4602 .
Ro 44602 .
Serazide .
Seryltrihydroxybenzylhydrazine .
An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. .
1.00
71036
 
Oxazepam .
Adumbran .
Serax .
Tazepam .
A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. .
0.59
71237
 
Ribavirin .
ICN-1229 .
Rebetol .
Ribamide .
Ribamidil .
Ribamidyl .
Ribasphere .
Vilona .
Viramide .
Virazide .
Virazole .
ICN 1229 .
ICN1229 .
Ribovirin .
Tribavirin .
A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. .
0.52
23510419
 
Hydrochlorothiazide .
Dichlothiazide .
Dihydrochlorothiazide .
Esidrex .
Esidrix .
HCTZ 5279 .
HydroDIURIL .
Hypothiazide .
Oretic .
Sectrazide .
A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. .
0.52
1375641
 
Fluticasone-Salmeterol Drug Combination .
Advair .
Advair Diskus .
Advair HFA .
Fluticasone - Salmeterol .
Fluticasone Propionate - Salmeterol .
Fluticasone Propionate - Salmeterol Combination .
Fluticasone Propionate - Salmeterol Xinafoate .
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination .
Fluticasone Propionate-Salmeterol Drug Combination .
Fluticasone Propionate-Salmeterol Xinafoate Combination .
Fluticasone Propionate-Salmeterol Xinafoate Drug Combination .
Fluticasone-Salmeterol Combination .
Seretide .
Combination, Fluticasone-Salmeterol .
Drug Combination, Fluticasone-Salmeterol .
Fluticasone Propionate Salmeterol .
Fluticasone Propionate Salmeterol Combination .
Fluticasone Propionate Salmeterol Drug Combination .
Fluticasone Propionate Salmeterol Xinafoate .
Fluticasone Propionate Salmeterol Xinafoate Combination .
Fluticasone Propionate Salmeterol Xinafoate Drug Combination .
Fluticasone Salmeterol .
Fluticasone Salmeterol Combination .
Fluticasone Salmeterol Drug Combination .
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. .
0.51
1336
 
Serine .
L-Serine .
L Serine .
A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. .
0.51
1220418
 
Selective Estrogen Receptor Modulators .
Estrogen Receptor Modulator, Selective .
SERM 22213 .
Selective Estrogen Receptor Modulator .
Estrogen Receptor Modulators, Selective .
SERMs .
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) .
0.50
503721
 
Seroma .
Seromas .
Tumor-like sterile accumulation of serum in a tissue, organ, or cavity. It results from a tissue insult and is the product of tissue inflammation. It most commonly occurs following MASTECTOMY. .
0.50
47842
 
Serum .
Blood Serum .
Serum, Blood .
Serums .
The clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins. .
0.49
926078